Molecular Assemblies

18 articles about Molecular Assemblies

• Molecular Assemblies Announces the Appointment of Two Industry Leaders to Its Commercial-Technology Advisory Board

  2/13/2024

  Molecular Assemblies, Inc. today announced the addition of two industry leaders to its Commercial-Technology Advisory Board (CTAB), which includes experts in the commercialization of nucleic acid technologies and innovative life science product solutions.

• Molecular Assemblies Ships First Enzymatically Synthesized Oligonucleotides

  3/14/2023

   Molecular Assemblies, Inc., a pioneer in the field of enzymatic DNA synthesis, today announced it has shipped the first enzymatically synthesized oligonucleotides to top biotechnology, academic, and synthetic biology researchers, delivered as part of a key customer program.

• Molecular Assemblies Appoints Mark Nibbe Vice President of Operations

  12/6/2022

  Molecular Assemblies, Inc., a pioneer in the field of enzymatic DNA synthesis, announced the appointment of Mark Nibbe as Vice President, Operations.

• Codexis and Molecular Assemblies Announce Execution of Commercial License and Enzyme Supply Agreement for Optimized TdT Enzyme for Enzymatic DNA Synthesis

  8/2/2022

  Codexis, Inc., a leading enzyme engineering company enabling the promise of synthetic biology, and Molecular Assemblies, Inc., a pioneer in the field of enzymatic DNA synthesis, announced the execution of a Commercial License and Enzyme Supply Agreement, enabling Molecular Assemblies to utilize an evolved terminal deoxynucleotidyl transferase enzyme in Molecular Assemblies’ Fully Enzymatic Synthesis™ technology.

• Molecular Assemblies Announces Jeffrey Sampson Joins Its Board of Directors

  6/8/2022

  Molecular Assemblies, Inc., a pioneer in the field of enzymatic DNA synthesis, announced the appointment of Jeffrey R. Sampson, Ph.D., to its Board of Directors.

• Molecular Assemblies to Provide Enzymatic Synthesis Technology to DARPA NOW Project for On-Demand DNA/RNA Vaccine Manufacturing

  3/2/2021

  Enzymatic synthesis to replace cumbersome chemical synthesis technology that requires hazardous chemicals and extensive post-synthesis processing

• 

  BioSpace Movers & Shakers, Dec. 11

  12/11/2020

  Biopharma and life science companies and organizations strengthen their leadership teams and boards with these Movers & Shakers.

• Molecular Assemblies Appoints Phil Paik, Ph.D., Vice President, Platform Development

  12/10/2020

  Dr. Paik's deep expertise in microfluidics and product development to be applied in advancing Molecular Assemblies' breakthrough enzymatic DNA synthesis technology into a commercial platform

• Molecular Assemblies Announces $12.2 M Series A Financing to Advance Enzymatic DNA Synthesis for Life Sciences and Data Storage

  10/1/2019

  Molecular Assemblies, Inc., announced that it has raised a $12.2 million Series A financing led by iSelect Fund and joined by existing investors, Agilent Technologies, Alexandria Venture Investments, and Keshif Ventures.

• Molecular Assemblies Expands Board of Directors

  8/6/2019

  Industry veterans from Thermo Fisher and Agilent join the board

• Molecular Assemblies Expands Patent Portfolio in Enzymatic DNA Synthesis

  9/18/2018

  The three issued patents are EP 3115462, US 10,041,110, and US 10,059,929.

• Molecular Assemblies Announces First Storage and Retrieval of Information with Enzymatic DNA Synthesis

  8/23/2018

  Molecular Assemblies Inc., a private biotech company developing proprietary enzymatic DNA synthesis technology, today announced that it has successfully completed an end-to-end run to store and retrieve digital information in DNA.

• Molecular Assemblies Inc. Announces First Storage and Retrieval of Information with Enzymatic DNA Synthesis

  8/23/2018

  Molecular Assemblies, Inc. announced that it has successfully completed an end-to-end run to store and retrieve digital information in DNA.

• Molecular Assemblies Expands Leadership Team with Appointment of Vice President of Chemistry and Biochemistry

  2/26/2018

  Molecular Assemblies Inc. today announced the appointment of Kim F. Albizati, PhD, as vice president of chemistry and biochemistry.

• Molecular Assemblies Appoints Nuvasive Executive Sean Freeman To Board Of Directors

  6/15/2017

• Molecular Assemblies Appoints Floyd E. Romesberg From The Scripps Research Institute To Scientific Advisory Board

  3/8/2017

• Molecular Assemblies Raises $2.3 Million In Seed Round

  12/12/2016

• Molecular Assemblies Names Biotech Veteran Michael J. Kamdar CEO

  10/20/2016